Fig. 5From: miRNA-106a directly targeting RARB associates with the expression of Na+/I− symporter in thyroid cancer by regulating MAPK signaling pathway a, transwell invasion assay in 8505C-miR106a(−) and control cells (*, P < 0.05); b, scratch-wound migration assay in 8505C-miR106a(−) and control cells (*, P < 0.05); c, transwell invasion assay in CGTH-W3-miR106a(+) and control cells (*, P < 0.05); d, scratch-wound migration assay in CGTH-W3-miR106a(+) and control cells (*, P < 0.05)Back to article page